Emmanuel B. Bache

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Emmanuel B. Bache, Sélidji Todagbé Agnandji, Bertrand Lell et al. · The Lancet · 2015 · 671 citations

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Sélidji Todagbé Agnandji, Angela Huttner, Madeleine E. Zinser et al. · New England Journal of Medicine · 2015 · 404 citations · Full text

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

Angela Huttner, Sélidji Todagbé Agnandji, Christophe Combescure et al. · The Lancet Infectious Diseases · 2018 · 79 citations · Full text

Vaccination, Single-dose Rvsv-zebov Vaccination, Antibody Persistence +7

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

Sélidji Todagbé Agnandji, José F. Fernandes, Emmanuel B. Bache et al. · PLoS Medicine · 2017 · 68 citations · Full text

Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections

Yuri Ushijima, Haruka Abe, Georgelin Nguema Ondo et al. · BMC Infectious Diseases · 2021 · 45 citations · Full text